title: Psychopharmacological therapies in dermatology.
abstract: When patients with psychodermatologic disorders present in clinic, the dermatologist can refer them to psychiatrists or other mental health care professionals. However, it is often the case that these patients will refuse a psychiatric referral because they either do not believe they have a disorder of psychiatric nature or they feel there is societal stigma associated with psychiatric illness. Therefore, it is essential for dermatologists to understand the common classifications for psychodermatological cases and to know how to optimally treat these patients with pharmacotherapy. The intent of this article is to help guide physicians in understanding the classifications of psychodermatological cases and in managing these conditions with pharmacotherapies. In this article, two classifications for psychodermatological cases are presented, followed by a discussion of medical therapies used to treat the main categories of psychopathologies that are more frequently encountered in dermatology. These include depression, anxiety, delusions, and obsessive-compulsive disorder.
authors.affiliation: UCSF Psoriasis and Skin Treatment Center, San Fancisco, CA 94118, USA. jillianwwong@gmail.com
authors.forename: Jillian W
authors.initials: JW
authors.lastname: Wong
authors.forename: John Y M
authors.initials: JY
authors.lastname: Koo
mesh_terms: D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D000982:Antipruritics / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy / Q000209:etiology / Q000523:psychology; D001828:Body Image / Q000523:psychology; D063726:Delusional Parasitosis / Q000188:drug therapy / Q000523:psychology; D003863:Depression / Q000188:drug therapy / Q000209:etiology / Q000523:psychology; D005162:Factitious Disorders / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D001523:Mental Disorders / Q000150:complications* / Q000188:drug therapy / Q000523:psychology; D009771:Obsessive-Compulsive Disorder / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D011602:Psychophysiologic Disorders / Q000188:drug therapy* / Q000523:psychology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D016728:Self-Injurious Behavior / Q000188:drug therapy; D012871:Skin Diseases / Q000209:etiology / Q000523:psychology*; D020886:Somatosensory Disorders / Q000188:drug therapy* / Q000523:psychology; D014256:Trichotillomania / Q000188:drug therapy / Q000209:etiology / Q000523:psychology
chemical_list: D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D000982:Antipruritics; D014150:Antipsychotic Agents; D011619:Psychotropic Drugs